Several recent developments have hallmarked progress in tumour immunology and immunotherapy. The use of interleukin-2 (IL-2) in cancer patients demonstrated that an immunological manipulation was capable of mediating the regression of established growing cancers in humans. The identification of the genes encoding cancer antigens and the development of means for effectively immunizing patients against these antigens has opened important new avenues of exploration for the development of effective active and cell-transfer immunotherapies for patients with cancer.

中文翻译：

---

免疫疗法在治疗癌症患者方面的进展。

近期的一些发展标志着肿瘤免疫学和免疫疗法的进步。在癌症患者中使用白介素2（IL-2）表明，免疫学操作能够介导人类中已建立的癌症的消退。编码癌症抗原的基因的鉴定以及针对这些抗原有效免疫患者的手段的开发为开发有效的针对癌症患者的活性和细胞转移免疫疗法开辟了重要的新途径。